PreferaOB ONE™

PreferaOB One by

Drug Labeling and Warnings

PreferaOB One by is a Prescription medication manufactured, distributed, or labeled by Alaven Pharmaceutical LLC, International Vitamin Corporation, Carton Services Inc. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

PREFERAOB ONE- folic acid, heme iron polypeptide, iron dextran, potassium iodide, zinc oxide, ascorbic acid, cholecalciferol, doconexent, .alpha.-tocopherol acetate, dl-, niacinamide, pyridoxine hydrochloride, cyanocobalamin, biotin and calcium pantothenate capsule capsule 
Alaven Pharmaceutical LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

PreferaOB ONE

Prenatal/Postnatal Multivitamin/
Multimineral/DHA softgel

Rx Only

DESCRIPTION

PreferaOB ONE is a prescription prenatal/postnatal multivitamin/multimineral nutritional supplement with Omega-3 fatty acid (life'sDHA1). PreferaOB ONE is an oblong shaped, opaque purple colored softgel, imprinted "AP 86" in white ink on one side and plain on the other.

Each PreferaOB ONE Softgel contains:

  • * Proferrin® is a registered trademark of Colorado Biolabs, Inc , Cozad, NE.
  • Vitamin C (as ascorbic acid)

    25 mg

    Vitamin D3 (as cholecalciferol)

    400 IU

    Vitamin E (as dl-alpha tocopheryl acetate)

    10 IU

    Vitamin B3 (niacin as niacinamide)

    17 mg

    Vitamin B6 (as pyridoxine HCl)

    50 mg

    Folic Acid

    1 mg

    Vitamin B12 (as cyanocobalamin)

    12 mcg

    Biotin

    30 mcg

    Vitamin B5 (as d-calcium pantothenate)

    10 mg

    Iron

     as PIC (polysaccharide iron complex)

    22 mg

     as HIP (heme iron polypeptide as

     Proferrin®* -bovine source, USDA certified)

    6 mg

    Iodine (as potassium iodide)

    175 mcg

    Zinc (as zinc oxide)

    15 mg

     

     

    Docosahexaenoic Acid (DHA)

    200 mg

    DHA is derived from the oils of microalgae, which is grown outside of the ocean, in a controlled environment, eliminating the risk of oceanic contamination.

    Inactive Ingredients

    Gelatin, soybean oil, yellow beeswax, and lecithin.


  • 1 life'sDHA is a trademark of Martek Biosciences Corporation, Columbia, MD.
  • INDICATIONS AND USAGE

    PreferaOB ONE is a prescription multivitamin/multimineral nutritional supplement with Omega-3 fatty acid (life'sDHA™) indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. PreferaOB ONE is also beneficial in improving the nutritional status of women prior to conception.

    CONTRAINDICATIONS

    This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

    WARNING

    Ingestion of more than 3 grams of Omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of Omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding diathesis.

    WARNING

    Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

    PRECAUTIONS

    Folic acid when administered as a single agent in doses above 0.1 mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. Pregnant women and nursing mothers should avoid supplemental doses of vitamin E higher than RDA amounts. While prescribing this nutritional supplement for pregnant women, nursing mothers, or for women prior to conception, their medical condition and other drugs, herbs, and/or supplements consumption should be considered.

    ADVERSE REACTIONS

    Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

    DOSAGE AND ADMINISTRATION

    One softgel daily with or without food, or as prescribed by a licensed health care provider with prescribing authority.

    HOW SUPPLIED

    PreferaOB ONE is supplied in child-resistant blister packs of 30 softgels (NDC: 68220-086-30) and as a Professional Sample (NDC: 68220-086-25).

    KEEP OUT OF REACH OF CHILDREN.

    STORAGE

    Store at controlled room temperature 20°-25°C (68°-77°F). Excursions permitted to 15°-30°C (59°-86°F). [See current USP]

    To protect from light, dispense in carton provided. Once open, blisters should be stored in carton.

    For medical inquiries call toll free
    1-888-317-0001

    www.PreferaOB.com

    Manufactured for:
    Alaven® Pharmaceutical LLC
    Marietta, GA 30062

    U.S. Patent No. 7,585,527

    PreferaOB® is a registered trademark and PreferaOB ONE is a trademark of Alaven® Pharmaceutical LLC, Marietta, GA.

    CL6-086-00-01-1209a

    PRINCIPAL DISPLAY PANEL - 30 Softgels Blister Package

    Rx Only
    NDC: 68220-086-30

    30 Softgels

    PreferaOB ONE

    The Prenatal YOU CAN COUNT ON!

    •   FIRST and ONLY prenatal with Natural,
      Body-Ready HEME Iron + DHA In
      an all-in-one softgel

    12 Essential Vitamins
    and Minerals including:

    - High dose of vitamin B6

    - 1mg of folic acid

    Plus Plant-based life'sDHA™ Omega-3

    Pre/Post-natal Nutritional

    Supplement + DHA

    life'sDHA™

    www.PreferaOB.com

    Chemical Structure
    PREFERAOB ONE 
    folic acid, heme iron polypeptide, iron dextran, potassium iodide, zinc oxide, ascorbic acid, cholecalciferol, doconexent, .alpha.-tocopherol acetate, dl-, niacinamide, pyridoxine hydrochloride, cyanocobalamin, biotin and calcium pantothenate capsule capsule
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 68220-086
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID1 mg
    HEME IRON POLYPEPTIDE (UNII: 31VDO12CJY) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION6 mg
    IRON DEXTRAN (UNII: 95HR524N2M) (FERRIC CATION - UNII:91O4LML611) FERRIC CATION22 mg
    POTASSIUM IODIDE (UNII: 1C4QK22F9J) (IODIDE ION - UNII:09G4I6V86Q) POTASSIUM IODIDE175 ug
    ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC CATION - UNII:13S1S8SF37) ZINC CATION15 ug
    ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID25 mg
    CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL400 [iU]
    DOCONEXENT (UNII: ZAD9OKH9JC) (DOCONEXENT - UNII:ZAD9OKH9JC) DOCONEXENT200 mg
    .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) (.ALPHA.-TOCOPHEROL, DL- - UNII:7QWA1RIO01) .ALPHA.-TOCOPHEROL, DL-10 [iU]
    NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE17 mg
    PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE50 mg
    CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204) CYANOCOBALAMIN12 ug
    BIOTIN (UNII: 6SO6U10H04) (BIOTIN - UNII:6SO6U10H04) BIOTIN30 ug
    CALCIUM PANTOTHENATE (UNII: 568ET80C3D) (PANTOTHENIC ACID - UNII:19F5HK2737) PANTOTHENIC ACID10 mg
    Inactive Ingredients
    Ingredient NameStrength
    HYDROGENATED SOYBEAN OIL (UNII: A2M91M918C) 58 mg
    YELLOW WAX (UNII: 2ZA36H0S2V) 34 mg
    GELATIN, UNSPECIFIED (UNII: 2G86QN327L)  
    LECITHIN, SOYBEAN (UNII: 1DI56QDM62) 10 mg
    Product Characteristics
    ColorPURPLEScoreno score
    ShapeCAPSULESize25mm
    FlavorImprint Code AP;86
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC: 68220-086-306 in 1 CARTON04/01/201001/01/2019
    1NDC: 68220-086-055 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC: 68220-086-251 in 1 CARTON04/01/201001/01/2019
    2NDC: 68220-086-055 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Unapproved drug other04/01/201001/01/2019
    Labeler - Alaven Pharmaceutical LLC (140210829)

    Revised: 3/2010
     
    Alaven Pharmaceutical LLC